Literature DB >> 6451805

Immunodeficiency associated with loss of T4+ inducer T-cell function.

E L Reinherz, R Geha, M E Wohl, C Morimoto, F S Rosen, S F Schlossman.   

Abstract

We investigated the immune function of a patient with anergy and acquired hypogammaglobulinemia. Despite normal numbers of B cells and T4+ inducer and T5+ suppressor T cells, this patient's lymphocytes did not produce immunoglobulin, proliferate in response to soluble antigens, or generate helper factors in vitro. In addition, her T4+ T cells did not express la molecules after stimulation by soluble antigen. In mixing experiments, her T cells did not induce immunoglobulin secretion by B cells from a normal, HLA-D-identical sibling; this failure was not due to excessive suppression, since the patient's T cells did not abrogate immunoglobulin production by the normal sibling's T and B cells. Moreover, the patient's B cells secreted immunoglobulin in the presence of the sibling's T4+ cells. In contrast to the deficient inducer cells, the patient's T5+ T cells were capable of expressing suppressor-cell functions. These results indicate that immunodeficiency may occur because of a selective loss of T4+ inducer function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451805     DOI: 10.1056/NEJM198104023041403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  The human T-cell receptor.

Authors:  O Acuto; M Fabbi; A Bensussan; C Milanese; T J Campen; H D Royer; E L Reinherz
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

2.  Chronic Giardiasis in a Case of Common Variable Immunodeficiency (CVID): A Case Report.

Authors:  Supriya M Paranjpe; Avani Koticha; Preeti R Mehta
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Authors:  F M Schaffer; J Palermos; Z B Zhu; B O Barger; M D Cooper; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  The capacity of interleukin-4 to induce in vitro IgE synthesis by B cells of patients with common variable immunodeficiency.

Authors:  G Pastorelli; M G Roncarolo; C Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

Authors:  N Okabe; K Fujita; M Yamasaki; T Yao; S Tsuru
Journal:  Gastroenterol Jpn       Date:  1985-10

6.  Intestinal nodular lymphoid hyperplasia in patients with common variable immunodeficiency: local accumulation of B and CD8(+) lymphocytes.

Authors:  P Van den Brande; K Geboes; G Vantrappen; A Van den Eeckhout; S Vertessen; E A Stevens; J L Ceuppens
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

7.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

8.  In vitro responses to a B-lymphoblastoid cell line in immunodeficiency diseases.

Authors:  J L Sullivan; H D Ochs; R J Wedgwood
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

9.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency.

Authors:  S Gupta; C E Ribak; S Gollapudi; C H Kim; S Z Salahuddin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.